GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » St Pharm Co Ltd (XKRX:237690) » Definitions » Debt-to-Revenue

St Pharm Co (XKRX:237690) Debt-to-Revenue : 0.26 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is St Pharm Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

St Pharm Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩73,375 Mil. St Pharm Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩44,767 Mil. St Pharm Co's annualized Revenue for the quarter that ended in Dec. 2024 was ₩462,941 Mil. St Pharm Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.26.


St Pharm Co Debt-to-Revenue Historical Data

The historical data trend for St Pharm Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Pharm Co Debt-to-Revenue Chart

St Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 0.65 0.54 0.67 0.43

St Pharm Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.89 0.89 0.49 0.26

Competitive Comparison of St Pharm Co's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


St Pharm Co's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where St Pharm Co's Debt-to-Revenue falls into.


;
;

St Pharm Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

St Pharm Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(73375.061 + 44766.815) / 273751.343
=0.43

St Pharm Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(73375.061 + 44766.815) / 462941.232
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


St Pharm Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of St Pharm Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


St Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.

St Pharm Co Headlines

No Headlines